TABLE OF CONTENTS
| | | | Volume 116, Issue 7 (841-971) Published online 28 March 2017
| | In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology
Also new today Advance online publication Digital Edition
| | | | | | Advertisement | | BACR 2017 Conferences The BACR hosts a number of specialist cancer meetings to bring together the latest thinking in cancer research. Having links with organisations such as EACR,NCRI and RSM boosts opportunities for networking and establishing collaborations with leaders in cancer research. Interested in attending/or presenting then visit www.bacr.org.uk/events | | | | | | | | Minireview | Top | | Study designs may influence results: the problems with questionnaire-based case–control studies on the epidemiology of gliomaChristoffer Johansen, Joachim Schüz, Anne-Marie Serena Andreasen and Susanne Oksbjerg Dalton Br J Cancer 2017 116: 841-848; advance online publication, March 7, 2017; 10.1038/bjc.2017.46 Abstract | Full Text | | Clinical Studies | Top | | Cancer-related fatigue management: evaluation of a patient education program with a large-scale randomised controlled trial, the PEPs fatigue studyA Bourmaud, A Anota, C Moncharmont, F Tinquaut, M Oriol, V Trillet-Lenoir, A Bajard, S Parnalland, C Rotonda, F Bonnetain, D Pérol and F Chauvin Br J Cancer 2017 116: 849-858; advance online publication, February 14, 2017; 10.1038/bjc.2017.31 Abstract | Full Text | | | | Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trialS E Pinder, A F Campbell, J M S Bartlett, A Marshall, D Allen, M Falzon, J A Dunn, A Makris, L Hughes-Davies and R C Stein on behalf of OPTIMA Trial Management Group Br J Cancer 2017 116: 859-863; advance online publication, February 21, 2017; 10.1038/bjc.2017.28 Abstract | Full Text | | | | Patients’ perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide surveyUlla-Sisko Lehto, Heli Tenhola, Kimmo Taari and Arpo Aromaa Br J Cancer 2017 116: 864-873; advance online publication, February 21, 2017; 10.1038/bjc.2017.30 Abstract | Full Text | | | | Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trialRoberto Pili, Glenn Liu, Sreenivasulu Chintala, Hendrick Verheul, Shabnam Rehman, Kristopher Attwood, Martin A Lodge, Richard Wahl, James I Martin, Kiersten Marie Miles, Silvia Paesante, Remi Adelaiye, Alejandro Godoy, Serina King, James Zwiebel and Michael A Carducci Br J Cancer 2017 116: 874-883; advance online publication, February 21, 2017; 10.1038/bjc.2017.33 Abstract | Full Text | | | | A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumoursRichard H Wilson, TR Jeffry Evans, Mark R Middleton, L Rhoda Molife, James Spicer, Veronique Dieras, Patricia Roxburgh, Heidi Giordano, Sarah Jaw-Tsai, Sandra Goble and Ruth Plummer Br J Cancer 2017 116: 884-892; advance online publication, February 21, 2017; 10.1038/bjc.2017.36 Abstract | Full Text | | Translational Therapeutics | Top | | PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotypeOnofrio Antonio Catalano, Gary Lloyd Horn, Alberto Signore, Carlo Iannace, Maria Lepore, Mark Vangel, Angelo Luongo, Marco Catalano, Constance Lehman, Marco Salvatore, Andrea Soricelli, Ciprian Catana, Umar Mahmood and Bruce Robert Rosen Br J Cancer 2017 116: 893-902; advance online publication, February 16, 2017; 10.1038/bjc.2017.26 Abstract | Full Text | | | | Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cellsXin Liang, Haiyang Shi, Liyan Yang, Cen Qiu, Shengchao Lin, Yingxue Qi, Jiyu Li, Aiguang Zhao and Jianwen Liu Br J Cancer 2017 116: 903-911; advance online publication, February 21, 2017; 10.1038/bjc.2017.32 Abstract | Full Text | | | | Inhibition of Cdk5 induces cell death of tumor-initiating cellsMelanie M Mandl, Siwei Zhang, Melanie Ulrich, Elisa Schmoeckel, Doris Mayr, Angelika M Vollmar and Johanna Liebl Br J Cancer 2017 116: 912-922; advance online publication, February 21, 2017; 10.1038/bjc.2017.39 Abstract | Full Text | | Molecular Diagnostics | Top | | Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancerRobert P Jones, Paul A Sutton, Jonathan P Evans, Rachel Clifford, Andrew McAvoy, James Lewis, Abigail Rousseau, Roger Mountford, Derek McWhirter and Hassan Z Malik Br J Cancer 2017 116: 923-929; advance online publication, February 16, 2017; 10.1038/bjc.2017.37 Abstract | Full Text | | | | Oncogenic role of PDK4 in human colon cancer cellsD Leclerc, D N T Pham, N Lévesque, M Truongcao, W D Foulkes, C Sapienza and R Rozen Br J Cancer 2017 116: 930-936; advance online publication, February 16, 2017; 10.1038/bjc.2017.38 Abstract | Full Text | | | | Intracrine androgen biosynthesis in renal cell carcinomaGeun Taek Lee, Christopher S Han, Young Suk Kwon, Rutveej Patel, Parth K Modi, Seok Joo Kwon, Izak Faiena, Neal Patel, Eric A Singer, Han-Jong Ahn, Wun-Jae Kim and Isaac Y Kim Br J Cancer 2017 116: 937-943; advance online publication, March 2, 2017; 10.1038/bjc.2017.42 Abstract | Full Text | | | | Predicting the presence of colon cancer in members of a health maintenance organisation by evaluating analytes from standard laboratory recordsRan Goshen, Barak Mizrahi, Pini Akiva, Yaron Kinar, Eran Choman, Varda Shalev, Victoria Sopik, Revital Kariv and Steven A Narod Br J Cancer 2017 116: 944-950; advance online publication, March 2, 2017; 10.1038/bjc.2017.53 Abstract | Full Text | | Epidemiology | Top | | Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO StudiesJessica L Petrick, Scott P Kelly, Linda M Liao, Neal D Freedman, Barry I Graubard and Michael B Cook Br J Cancer 2017 116: 951-959; advance online publication, February 14, 2017; 10.1038/bjc.2017.29 Abstract | Full Text | | | | Gestational diabetes mellitus may be associated with increased risk of breast cancerYong-Moon Mark Park, Katie M O'Brien, Shanshan Zhao, Clarice R Weinberg, Donna D Baird and Dale P Sandler Br J Cancer 2017 116: 960-963; advance online publication, February 16, 2017; 10.1038/bjc.2017.34 Abstract | Full Text | | | | Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancerShana J Kim, Barry Rosen, Isabel Fan, Anna Ivanova, John R McLaughlin, Harvey Risch, Steven A Narod and Joanne Kotsopoulos Br J Cancer 2017 116: 964-971; advance online publication, February 16, 2017; 10.1038/bjc.2017.35 Abstract | Full Text | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | | | | |
No comments:
Post a Comment